Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 1
2009 4
2011 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.
Steele CW, Oien KA, McKay CJ, Jamieson NB. Steele CW, et al. Pancreas. 2011 Nov;40(8):1165-71. doi: 10.1097/MPA.0b013e3182218ffb. Pancreas. 2011. PMID: 22001830 Review.
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
Kan T, Meltzer SJ. Kan T, et al. Curr Opin Pharmacol. 2009 Dec;9(6):727-32. doi: 10.1016/j.coph.2009.08.009. Epub 2009 Sep 19. Curr Opin Pharmacol. 2009. PMID: 19773200 Free PMC article. Review.
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.
Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. Yanaihara N, et al. Cancer Cell. 2006 Mar;9(3):189-98. doi: 10.1016/j.ccr.2006.01.025. Cancer Cell. 2006. PMID: 16530703 Free article.
A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese.
Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y, Shen H. Tian T, et al. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1183-7. doi: 10.1158/1055-9965.EPI-08-0814. Epub 2009 Mar 17. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19293314 Free article.
Genome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin-resistant gastric cancer cells.
Wu XM, Shao XQ, Meng XX, Zhang XN, Zhu L, Liu SX, Lin J, Xiao HS. Wu XM, et al. Acta Pharmacol Sin. 2011 Feb;32(2):259-69. doi: 10.1038/aps.2010.204. Acta Pharmacol Sin. 2011. PMID: 21293479 Free PMC article.
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Michael MZ, et al. Mol Cancer Res. 2003 Oct;1(12):882-91. Mol Cancer Res. 2003. PMID: 14573789 Free article.
Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals.
Luzna P, Gregar J, Uberall I, Radova L, Prochazka V, Ehrmann J Jr. Luzna P, et al. Diagn Pathol. 2011 Nov 17;6:114. doi: 10.1186/1746-1596-6-114. Diagn Pathol. 2011. PMID: 22094011 Free PMC article.
MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease.
Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, Frazier ML, Killary AM, Sen S. Wang J, et al. Cancer Prev Res (Phila). 2009 Sep;2(9):807-13. doi: 10.1158/1940-6207.CAPR-09-0094. Epub 2009 Sep 1. Cancer Prev Res (Phila). 2009. PMID: 19723895 Free PMC article.
Expression profiling identifies microRNA signature in pancreatic cancer.
Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD. Lee EJ, et al. Int J Cancer. 2007 Mar 1;120(5):1046-54. doi: 10.1002/ijc.22394. Int J Cancer. 2007. PMID: 17149698 Free PMC article.
MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.
Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R. Maru DM, et al. Am J Pathol. 2009 May;174(5):1940-8. doi: 10.2353/ajpath.2009.080718. Epub 2009 Mar 26. Am J Pathol. 2009. PMID: 19342367 Free PMC article.